SPOTLIGHT: Big Pharma making big cuts

Johnson & Johnson is just one of many Pharma companies to announce big layoffs. In a company-wide restructuring, J&J said it would cut 4,800 jobs--and this was after 10,000 layoffs at Pfizer, 7,000 at Merck and 7,600 at AstraZeneca. The industry's been beleaguered by competition from generics and thin R&D pipelines, but some analysts blame Wall Street's unrealistic expectations for constant, double-digit earnings growth. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.